Shengnuo biotechnology exhibits in the 20th CPHI China
On December 16, 2020, the 20th world pharmaceutical raw materials China Exhibition (CPHI China) was solemnly opened in Shanghai New International Expo Center.
It has been 19 years since its establishment in 2001. The flowers are similar year by year, but the people are different year by year. Looking back on the past, with the support of our customers, our company has developed a certain market fighting ability after 19 years of market honing. Looking forward to the future, our company will go to a higher level, determined to bring the world;
Shengnuo biotechnology: Sichuan, but also the world.
2020 is tough, but warm. If we use a few words to describe it, it is “epidemic, accident; structure, differentiation; reform and innovation”. This is an extraordinary year.
Numerous health care providers have provided strong support for the fight against the epidemic.
The epidemic has accelerated the Internet diagnosis and treatment, and Internet hospitals have been implemented.
Relevant national policies and standards have been introduced frequently, and all kinds of demands from management to business departments are roaring.
This year, we have experienced too much
Shengnuo biotechnology millions of drugs rush to Wuhan
In February 22, 2020, novel coronavirus pneumonia donation ceremony was held outside San Nuo biological company.
The donation totaled more than 1.5 million yuan worth of drugs, including 32 pieces of thymopentin 16000 bottles and 38 pieces of thymosin 12160 bottles, which were transported to major hospitals in Wuhan to support the first-line epidemic situation.
Shengnuo biotechnology Suzhou CMC Expo
On October 22, 2020, shengnuo biotechnology was invited to participate in the drug finance circle, and joined hands with baiaogu to launch the Expo with the theme of “improving R & D efficiency and reducing manufacturing cost” in Suzhou on October 22 and 23.
The Expo invited more than 100 drug supervision leaders, industry celebrities, more than 20 persons in charge of listed companies and more than 500 entrepreneurs, which was unprecedented.
The Expo mainly focuses on the sharing and exchange of more than 50 hot topics and technology hotspots of China’s biomedicine.
It seeks the best technology development, consulting, clinical and entrusted processing services in the fields of API, preparation and biomedicine for the participating enterprises, interacts with celebrities to understand forward-looking information,
exchanges with enterprise experts to obtain practical experience, and differentiates frontline trends with scientific research scholars.
Through this Expo, shengnuo biotechnology has benefited a lot. It will take this opportunity to continuously deepen exchanges and cooperation with industries in various regions and countries, and make new contributions to the construction of human health industry.
Shengnuo biotechnology exhibits in the 20th CPHI China
On December 16, 2020, the 20th world pharmaceutical raw materials China Exhibition (CPHI China) was solemnly opened in Shanghai New International Expo Center.
This time, Chengdu suno biopharmaceutical priority Co., Ltd. also accepted the invitation to go to the destination to exchange views with the predecessors in the pharmaceutical industry from all over the world.
During the exhibition, shengnuo biotechnology actively publicized the company’s products, had face-to-face communication with partners and target customers, and through the interpretation of the current professional technology of shengnuo biotechnology and the application analysis of various products by the exhibitors, the visitors could have a more comprehensive and detailed understanding of the enterprise situation of shengnuo biotechnology.
At the same time, it also plays a positive role in promoting the market promotion of bio products and technologies, and promoting the internationalization process of bio.
And through the display of products and technology and the expansion of business level, we will continue to open up a new dual cycle journey of domestic and international pharmaceutical trade.
……
Looking back on 2020, we have experienced ups and downs, feeling for the time we spent together; we continue to explore and move forward, and are proud of the achievements we have made together;
although there are many unknowns waiting for us in 2021, we still believe that next year’sshengnuo biotechnology will make brilliant achievements again!
Today, we are going to say goodbye to 2020. We praise the development achievements of shengnuo biotechnology, send our best wishes to the employees who are working hard in the front line all year round, and say happy New Year’s day, happiness and health to them!